BMS makes Frances Heller SVP
This article was originally published in Scrip
Bristol-Myers Squibb has appointed Frances Heller senior vice-president of business development, effective from 1 October 2012. She will report to Lamberto Andreotti, the company's CEO. Ms Heller most recently served as executive vice-president of business development at Exelixis, and was previously head of strategic alliances at Novartis.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.